Literature DB >> 27114538

α/β-Hydrolase domain-containing 6 (ABHD6) negatively regulates the surface delivery and synaptic function of AMPA receptors.

Mengping Wei1, Jian Zhang1, Moye Jia1, Chaojuan Yang1, Yunlong Pan1, Shuaiqi Li1, Yiwen Luo1, Junyuan Zheng1, Jianguo Ji1, Jianguo Chen1, Xinli Hu2, Jingwei Xiong2, Yun Shi3, Chen Zhang4.   

Abstract

In the brain, AMPA-type glutamate receptors are major postsynaptic receptors at excitatory synapses that mediate fast neurotransmission and synaptic plasticity. α/β-Hydrolase domain-containing 6 (ABHD6), a monoacylglycerol lipase, was previously found to be a component of AMPA receptor macromolecular complexes, but its physiological significance in the function of AMPA receptors (AMPARs) has remained unclear. The present study shows that overexpression of ABHD6 in neurons drastically reduced excitatory neurotransmission mediated by AMPA but not by NMDA receptors at excitatory synapses. Inactivation of ABHD6 expression in neurons by either CRISPR/Cas9 or shRNA knockdown methods significantly increased excitatory neurotransmission at excitatory synapses. Interestingly, overexpression of ABHD6 reduced glutamate-induced currents and the surface expression of GluA1 in HEK293T cells expressing GluA1 and stargazin, suggesting a direct functional interaction between these two proteins. The C-terminal tail of GluA1 was required for the binding between of ABHD6 and GluA1. Mutagenesis analysis revealed a GFCLIPQ sequence in the GluA1 C terminus that was essential for the inhibitory effect of ABHD6. The hydrolase activity of ABHD6 was not required for the effects of ABHD6 on AMPAR function in either neurons or transfected HEK293T cells. Thus, these findings reveal a novel and unexpected mechanism governing AMPAR trafficking at synapses through ABHD6.

Entities:  

Keywords:  ABHD6; AMPA receptor; receptor trafficking; synapses

Mesh:

Substances:

Year:  2016        PMID: 27114538      PMCID: PMC4868484          DOI: 10.1073/pnas.1524589113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  82 in total

1.  High-resolution proteomics unravel architecture and molecular diversity of native AMPA receptor complexes.

Authors:  Jochen Schwenk; Nadine Harmel; Aline Brechet; Gerd Zolles; Henrike Berkefeld; Catrin Swantje Müller; Wolfgang Bildl; David Baehrens; Björn Hüber; Akos Kulik; Nikolaj Klöcker; Uwe Schulte; Bernd Fakler
Journal:  Neuron       Date:  2012-05-24       Impact factor: 17.173

Review 2.  Inhibitors of the endocannabinoid-degrading enzymes, or how to increase endocannabinoid's activity by preventing their hydrolysis.

Authors:  Marion Feledziak; Didier M Lambert; Jacqueline Marchand-Brynaert; Giulio G Muccioli
Journal:  Recent Pat CNS Drug Discov       Date:  2012-04-01

3.  Biochemical and pharmacological characterization of human α/β-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12).

Authors:  Dina Navia-Paldanius; Juha R Savinainen; Jarmo T Laitinen
Journal:  J Lipid Res       Date:  2012-09-11       Impact factor: 5.922

4.  Multiplex genome engineering using CRISPR/Cas systems.

Authors:  Le Cong; F Ann Ran; David Cox; Shuailiang Lin; Robert Barretto; Naomi Habib; Patrick D Hsu; Xuebing Wu; Wenyan Jiang; Luciano A Marraffini; Feng Zhang
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

5.  Highly predictive ligand-based pharmacophore and homology models of ABHD6.

Authors:  Anna L Bowman; Alexandros Makriyannis
Journal:  Chem Biol Drug Des       Date:  2012-12-26       Impact factor: 2.817

6.  Cornichons modify channel properties of recombinant and glial AMPA receptors.

Authors:  Ian D Coombs; David Soto; Marzieh Zonouzi; Massimiliano Renzi; Chris Shelley; Mark Farrant; Stuart G Cull-Candy
Journal:  J Neurosci       Date:  2012-07-18       Impact factor: 6.167

7.  Differences in AMPA and kainate receptor interactomes facilitate identification of AMPA receptor auxiliary subunit GSG1L.

Authors:  Natalie F Shanks; Jeffrey N Savas; Tomohiko Maruo; Ondrej Cais; Atsushi Hirao; Souichi Oe; Anirvan Ghosh; Yasuko Noda; Ingo H Greger; John R Yates; Terunaga Nakagawa
Journal:  Cell Rep       Date:  2012-05-23       Impact factor: 9.423

8.  Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex.

Authors:  Leonora E Long; Jonna Lind; Maree Webster; Cynthia Shannon Weickert
Journal:  BMC Neurosci       Date:  2012-07-24       Impact factor: 3.288

9.  LTP requires a reserve pool of glutamate receptors independent of subunit type.

Authors:  Adam J Granger; Yun Shi; Wei Lu; Manuel Cerpas; Roger A Nicoll
Journal:  Nature       Date:  2012-12-12       Impact factor: 49.962

10.  RNA-programmed genome editing in human cells.

Authors:  Martin Jinek; Alexandra East; Aaron Cheng; Steven Lin; Enbo Ma; Jennifer Doudna
Journal:  Elife       Date:  2013-01-29       Impact factor: 8.140

View more
  25 in total

Review 1.  Control of excessive neural circuit excitability and prevention of epileptic seizures by endocannabinoid signaling.

Authors:  Yuki Sugaya; Masanobu Kano
Journal:  Cell Mol Life Sci       Date:  2018-05-08       Impact factor: 9.261

2.  GSG1L regulates the strength of AMPA receptor-mediated synaptic transmission but not AMPA receptor kinetics in hippocampal dentate granule neurons.

Authors:  Xia Mao; Xinglong Gu; Wei Lu
Journal:  J Neurophysiol       Date:  2016-10-05       Impact factor: 2.714

Review 3.  ABHD6: Its Place in Endocannabinoid Signaling and Beyond.

Authors:  Jessica K Cao; Joshua Kaplan; Nephi Stella
Journal:  Trends Pharmacol Sci       Date:  2019-03-07       Impact factor: 14.819

4.  Identification of Protein Tyrosine Phosphatase Receptor Type O (PTPRO) as a Synaptic Adhesion Molecule that Promotes Synapse Formation.

Authors:  Wei Jiang; Mengping Wei; Mengna Liu; Yunlong Pan; Dong Cao; Xiaofei Yang; Chen Zhang
Journal:  J Neurosci       Date:  2017-09-04       Impact factor: 6.167

Review 5.  Lipid-metabolizing serine hydrolases in the mammalian central nervous system: endocannabinoids and beyond.

Authors:  Myungsun Shin; Timothy B Ware; Hyeon-Cheol Lee; Ku-Lung Hsu
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-08-16       Impact factor: 4.698

6.  CRISPR/Cas9 system-mediated impairment of synaptobrevin/VAMP function in postmitotic hippocampal neurons.

Authors:  Patricia M Horvath; Ege T Kavalali; Lisa M Monteggia
Journal:  J Neurosci Methods       Date:  2016-12-23       Impact factor: 2.390

7.  Phenotypic Characterization of the Endocannabinoid-Degrading Enzyme Alpha/Beta-Hydrolase Domain 6 Knockout Rat.

Authors:  Katsuhiko Noguchi; Katsumi Kadekawa; Saori Nishijima; Mayuko Sakanashi; Shiho Okitsu-Sakurayama; Sayomi Higa-Nakamine; Hideyuki Yamamoto; Kimio Sugaya
Journal:  Cannabis Cannabinoid Res       Date:  2021-08-31

8.  Phosphorylation of CRMP2 by Cdk5 Negatively Regulates the Surface Delivery and Synaptic Function of AMPA Receptors.

Authors:  Longfei Cheng; Keen Chen; Jiong Li; Jiaming Wu; Jiaqi Zhang; Li Chen; Guoqing Guo; Jifeng Zhang
Journal:  Mol Neurobiol       Date:  2021-11-12       Impact factor: 5.682

9.  ABHD6 Controls Amphetamine-Stimulated Hyperlocomotion: Involvement of CB1 Receptors.

Authors:  Liting Deng; Katie Viray; Simar Singh; Ben Cravatt; Nephi Stella
Journal:  Cannabis Cannabinoid Res       Date:  2021-10-27

Review 10.  Transcriptomic expression of AMPA receptor subunits and their auxiliary proteins in the human brain.

Authors:  Kevin Shen; Agenor Limon
Journal:  Neurosci Lett       Date:  2021-04-26       Impact factor: 3.197

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.